EUVIMEDEUVIMED entdecken
Crossref

Modified Ross procedure with pulmonary autograft reinforcement within a Valsalva Dacron graft: long-term results

Thomas Denisselle iD, Marie Jungling, Natacha Rousse, Francis Juthier, Alain Prat, Valentin Loobuyck, Agnès Mugnier, Astrid Monier, Gabriella Ricciardi, Carlo Banfi, Olivia Domanski, François Godart und 6 weitere

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Thomas Denisselle und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery, Université de Lille, CHU Lille, Lille, France. Hauptthemen laut MEDLINE: Aortic Valve, Pulmonary Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES The Ross procedure allows the replacement of a diseased aortic valve with a living valvular substitute and provides a normal life span. However, progressive autograft dilatation and subsequent neoaortic valve regurgitation leading to reoperations remain major drawbacks. Our objective was to assess the long-term outcomes of our modified Ross technique with pulmonary autograft reinforcement in a Valsalva Dacron graft. METHODS Data from all patients who underwent a modified Ross procedure in our institution between 2003 and 2020 were reviewed retrospectively. RESULTS One hundred eighty-nine patients were included in this study. Median age at surgery was 31 years [interquartile range (IQR) 22.5–38.7]. Patients were predominantly male (74.1%) and with bicuspid aortic valve (90.5%). Indication for surgery was pure aortic regurgitation in 40.2%, pure aortic stenosis in 30.7%, mixed lesion in 26.5% and prosthetic valve failure in 2.7%. Median cardiopulmonary bypass and aortic cross-clamping times were 135 (IQR 120–171.5) and 114 (IQR 101.5–1423.5) min, respectively Three perioperative deaths occurred (1.6%). Median follow-up was 8.6 years (IQR 5.3–11.5); three late deaths occurred. Overall survival rate was 96.6% at both 5 and 10 years. Ten patients underwent 11 late autograft reinterventions. Freedom from autograft reoperation was 95.8% and 95.0% at 5 and 10 years, respectively. The main indication for autograft reoperation was neoaortic regurgitation due to cusp prolapse. With death as a competing outcome, we observed a trend towards an increased risk for autograft reintervention in patients with pure preoperative aortic regurgitation (sub-hazard ratio 4.47, P = 0.057; 95% confidence interval 0.95–20.9). CONCLUSIONS The modified Ross procedure with inclusion of the pulmonary autograft using a Valsalva Dacron graft showed excellent results at 10 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValvePulmonary ValveHeart Valve Prosthesis ImplantationHumansMaleRetrospective StudiesAdultFemalePolyethylene TerephthalatesYoung AdultAortic Valve InsufficiencyHeart Valve ProsthesisTreatment OutcomeReoperationAortic Valve StenosisAutograftsBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationTransplantation, Autologous

Stichwörter der Autor:innen

Aortic rootPulmonary autograftReinforcementRoss procedure

Substanzen

Polyethylene Terephthalates

Autor:innen und Institutionen

  • Cardiac Surgery, Université de Lille, CHU Lille, Lille, France.
  • ULR 2694-Technologies de Santé et des Pratiques Médicales, Université de Lille, CHU Lille, Lille, France.
  • Department of Cardiothoracic Surgery, Istituto Clinico Sant'Ambrogio, Gruppo Ospedaliero San Donato Milan, University of Milan, Milan, Italy.
  • Pediatric Cardiology, Université de Lille, CHU Lille, Lille, France.
  • Clinical Physiology and Echocardiography, Université de Lille, CHU Lille, Lille, France.
  • Cardiovascular Anesthesia and Intensive Care, Université de Lille, CHU Lille, Lille, France.

ORCID-Profile: Thomas Denisselle, Jerome Soquet, André Vincentelli

Zitieren

APA

Denisselle, T., Jungling, M., Rousse, N., Juthier, F., Prat, A., Loobuyck, V., Mugnier, A., Monier, A., Ricciardi, G., Banfi, C., Domanski, O., Godart, F., Richardson, M., Coisne, A., Moussa, M. D., Robin, E., Soquet, J., & Vincentelli, A. (2025). Modified Ross procedure with pulmonary autograft reinforcement within a Valsalva Dacron graft: long-term results. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf133

Vancouver

Denisselle T, Jungling M, Rousse N, Juthier F, Prat A, Loobuyck V, et al. Modified Ross procedure with pulmonary autograft reinforcement within a Valsalva Dacron graft: long-term results. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf133

BibTeX
@article{Denisselle2025,
  author = {Denisselle, Thomas and Jungling, Marie and Rousse, Natacha and Juthier, Francis and Prat, Alain and Loobuyck, Valentin and Mugnier, Agnès and Monier, Astrid and Ricciardi, Gabriella and Banfi, Carlo and Domanski, Olivia and Godart, François and Richardson, Marjorie and Coisne, Augustin and Moussa, Mouhamed Djahoum and Robin, Emmanuel and Soquet, Jerome and Vincentelli, André},
  title = {Modified Ross procedure with pulmonary autograft reinforcement within a Valsalva Dacron graft: long-term results},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf133}
}
Kostenlos starten →